PortfoliosLab logo

Horizon Therapeutics Public Limited Company (HZNP)

Equity · Currency in USD · Last updated Dec 8, 2022

Company Info

ISINIE00BQPVQZ61
CUSIP00BQPVQZ6
SectorHealthcare
IndustryDrug Manufacturers—General

Trading Data

Previous Close$96.30
Year Range$58.92 - $116.36
EMA (50)$77.22
EMA (200)$82.10
Average Volume$3.02M
Market Capitalization$21.95B

HZNPShare Price Chart


Loading data...

HZNPPerformance

The chart shows the growth of $10,000 invested in Horizon Therapeutics Public Limited Company in Jul 2011 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $105,246 for a total return of roughly 952.46%. All prices are adjusted for splits and dividends.


-30.00%-20.00%-10.00%0.00%10.00%20.00%JulyAugustSeptemberOctoberNovemberDecember
12.74%
0.85%
HZNP (Horizon Therapeutics Public Limited Company)
Benchmark (^GSPC)

HZNPCompare to other instruments

Search for stocks, ETFs, and funds to compare with HZNP

HZNPReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M24.84%4.33%
6M5.06%-5.45%
YTD-10.63%-17.46%
1Y-2.29%-14.32%
5Y46.06%8.35%
10Y45.68%10.76%

HZNPMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-13.39%-2.31%15.40%-6.32%-9.00%-11.07%4.02%-28.64%4.53%0.69%60.93%-3.98%
2021-0.92%25.43%1.24%2.80%-3.13%2.16%6.81%8.07%1.34%9.47%-13.47%3.86%
2020-4.72%-0.78%-13.44%21.67%40.76%9.56%10.09%22.77%3.41%-3.54%-6.01%3.86%
20199.98%34.99%-8.89%-3.41%-6.66%0.97%3.45%11.01%-1.45%6.17%13.39%10.43%
2018-0.34%0.21%-2.61%-6.76%23.11%1.60%6.46%19.91%-7.38%-7.00%9.72%-2.20%
20171.17%-1.95%-7.91%4.06%-34.98%18.70%0.93%14.19%-7.31%6.94%6.05%1.53%
2016-19.24%-1.94%-3.44%-7.24%12.10%-4.41%17.12%-2.54%-3.56%-7.78%18.42%-18.28%
201527.46%24.95%26.50%8.28%15.33%7.12%6.07%-20.71%-32.17%-20.69%36.96%0.65%
201429.40%23.94%23.73%-6.22%0.07%11.49%-46.21%21.03%19.22%5.37%-1.24%0.86%
2013-8.58%-0.94%28.44%-11.44%-1.25%3.80%2.44%0.40%32.41%25.07%72.32%5.54%
2012-0.75%-13.10%20.00%1.45%-4.76%78.25%-19.92%-22.24%-21.17%-26.29%0.39%-10.04%
2011-1.20%-11.50%-12.62%28.61%-42.05%-23.22%

HZNPSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Horizon Therapeutics Public Limited Company Sharpe ratio is -0.11. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.20-1.00-0.80-0.60-0.40-0.200.00JulyAugustSeptemberOctoberNovemberDecember
-0.11
-0.67
HZNP (Horizon Therapeutics Public Limited Company)
Benchmark (^GSPC)

HZNPDividend History


Horizon Therapeutics Public Limited Company doesn't pay dividends

HZNPDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%2022FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember
-19.69%
-17.98%
HZNP (Horizon Therapeutics Public Limited Company)
Benchmark (^GSPC)

HZNPWorst Drawdowns

The table below shows the maximum drawdowns of the Horizon Therapeutics Public Limited Company. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Horizon Therapeutics Public Limited Company is 78.25%, recorded on Mar 4, 2013. It took 229 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-78.25%Jul 29, 2011400Mar 4, 2013229Jan 29, 2014629
-74.92%Jul 22, 2015455May 10, 2017678Jan 22, 20201133
-52.36%Mar 24, 201489Jul 29, 2014142Feb 20, 2015231
-50.86%Nov 1, 2021209Aug 30, 2022
-35.5%Jan 23, 202042Mar 23, 202031May 6, 202073
-20.61%Oct 12, 202050Dec 21, 202028Feb 2, 202178
-16.02%Feb 25, 202123Mar 29, 202140May 25, 202163
-13.01%Apr 27, 201510May 8, 201510May 22, 201520
-10.73%Mar 20, 20154Mar 25, 20153Mar 30, 20157
-9.32%Jun 1, 20209Jun 11, 20207Jun 22, 202016

HZNPVolatility Chart

Current Horizon Therapeutics Public Limited Company volatility is 136.49%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%120.00%140.00%JulyAugustSeptemberOctoberNovemberDecember
136.49%
22.83%
HZNP (Horizon Therapeutics Public Limited Company)
Benchmark (^GSPC)